Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration. 1998

Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
Department of Biochemistry, School of Medicine, University of Occupational and Environmental Health, Fukuoka.

Carcinogen-resistant inbred DRH rats developed from the Donryu strain showed a remarkably low incidence of liver tumors when they were fed diets containing hepatocarcinogens such as 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB). In this work, we examined various characteristics of male DRH and Donryu rats during 3'-Me-DAB administration for 8 weeks. 32P-Postlabeling analysis showed that essentially similar levels of DNA-adducts were generated by the metabolites of 3'-Me-DAB in the livers of these two strains of rats at several time points. However, both GADD45 (growth arrest and DNA damage-inducible) and O6-methylguanine methyltransferase (putatively DNA damage-inducible) mRNA levels were increased significantly in Donryu rat livers, but were increased to a lesser extent in DRH rats. [3H]Thymidine incorporation into hepatic DNA began to increase around 10 to 20 days after the start of 3'-Me-DAB administration in Donryu rats probably due to DNA repair, while no significant change occurred in DRH rats under the same conditions. Furthermore, inductions of heme oxygenase (due to degradation of heme-proteins) and hepatocyte growth factor (HGF; cell death and regeneration of hepatocytes) mRNAs were greater in Donryu rat livers than those of DRH, suggesting that the former were more sensitive to cytotoxic effects of 3'-Me-DAB than the latter. Another remarkable difference observed between these two strains was the significant induction of cytochrome P-450 2E1 mRNA in Donryu rat livers; this may contribute to the generation of reactive oxygen intermediates. Finally, increases of glutathione S-transferase (P-form) and gamma-glutamyltranspeptidase mRNAs as marker enzymes of preneoplastic changes of hepatocytes were clearly seen only in Donryu rat livers at 6 to 8 weeks after the start of 3'-Me-DAB administration. These results indicate that the different susceptibility to hepatocarcinogenesis between these two strains of rats may arise from events other than the DNA adduct formation.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D008749 Methyldimethylaminoazobenzene A very potent liver carcinogen. MeDAB,3'-Methyl-4-dimethylaminoazobenzene,Dimethyl-p-(m-tolylazo)aniline,3' Methyl 4 dimethylaminoazobenzene
D010761 Phosphorus Radioisotopes Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. Radioisotopes, Phosphorus
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug

Related Publications

Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
December 1999, Japanese journal of cancer research : Gann,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
February 1970, Chemico-biological interactions,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
March 1952, Cancer research,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
January 1950, Cancer research,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
May 1967, The Biochemical journal,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
June 1970, Cancer research,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
September 1972, Cancer research,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
January 1974, Biochemical and biophysical research communications,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
March 1953, Cancer research,
Y Yan, and K Higashi, and K Yamamura, and Y Fukamachi, and T Abe, and S Gotoh, and T Sugiura, and T Hirano, and T Higashi, and M Ichiba
March 1953, Cancer research,
Copied contents to your clipboard!